Nek2 kinase in chromosome instability and cancer

被引:142
作者
Hayward, Daniel G. [1 ]
Fry, Andrew M. [1 ]
机构
[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
Nek2A; Nek2B; centrosome; mitosis; aneuploidy;
D O I
10.1016/j.canlet.2005.06.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aneuploidy and chromosome instability are two of the most common abnormalities in cancer cells. They arise through defects in cell division and, specifically, in the unequal segregation of chromosomes between daughter cells during mitosis. A number of cell cycle dependent protein kinases have been identified that control mitotic progression and chromosome segregation. Some of these localize to the centrosome and regulate mitotic spindle formation. One such protein is Nek2, a member of the NIMA-related serine/threonine kinase family. Data are emerging that Nek2 is abnormally expressed in a wide variety of human cancers. In this review, we summarize current knowledge on the expression, regulation and function of Nek2, consider how Nek2 may contribute to chromosome instability, and ask whether it might make an attractive target for chemotherapeutic intervention in human cancer. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 64 条
[31]   The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer [J].
Hayward, DG ;
Clarke, RB ;
Faragher, AJ ;
Pillai, MR ;
Hagan, IM ;
Fry, AM .
CANCER RESEARCH, 2004, 64 (20) :7370-7376
[32]   NIMA-related kinase 2 (Nek2), a cell-cycle-regulated protein kinase localized to centrosomes, is complexed to protein phosphatase 1 [J].
Helps, NR ;
Luo, X ;
Barker, HM ;
Cohen, PTW .
BIOCHEMICAL JOURNAL, 2000, 349 :509-518
[33]   Aurora-kinase inhibitors as anticancer agents [J].
Keen, N ;
Taylor, S .
NATURE REVIEWS CANCER, 2004, 4 (12) :927-936
[34]   Nek2 localizes to multiple sites in mitotic cells, suggesting its involvement in multiple cellular functions during the cell cycle [J].
Kim, YH ;
Choi, JY ;
Jeong, Y ;
Wolgemuth, DJ ;
Rhee, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (02) :730-736
[35]  
Krien MJE, 1998, J CELL SCI, V111, P967
[36]   FoxM1 is required for execution of the mitotic programme and chromosome stability [J].
Laoukili, J ;
Kooistra, MRH ;
Brás, A ;
Kauw, J ;
Kerkhoven, RM ;
Morrison, A ;
Clevers, H ;
Medema, RH .
NATURE CELL BIOLOGY, 2005, 7 (02) :126-U34
[37]   Centrosome amplification drives chromosomal instability in breast tumor development [J].
Lingle, WL ;
Barrett, SL ;
Negron, VC ;
D'Assoro, AB ;
Boeneman, K ;
Liu, WG ;
Whitehead, CM ;
Reynolds, C ;
Salisbury, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :1978-1983
[38]   Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK [J].
Lo, YL ;
Yu, JC ;
Chen, ST ;
Yang, HC ;
Farm, CSJ ;
Mau, YC ;
Shen, CY .
INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (02) :276-283
[39]   Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes [J].
Loo, LWM ;
Grove, DI ;
Williams, EM ;
Neal, CL ;
Cousens, LA ;
Schubert, EL ;
Holcomb, IN ;
Massa, HF ;
Glogovac, J ;
Li, CI ;
Malone, KE ;
Daling, JR ;
Delrow, JJ ;
Trask, BJ ;
Hsu, L ;
Porter, PL .
CANCER RESEARCH, 2004, 64 (23) :8541-8549
[40]   NEK2A interacts with MAD1 and possibly functions as a novel integrator of the spindle checkpoint signaling [J].
Lou, Y ;
Yao, JH ;
Zereshki, A ;
Dou, Z ;
Ahmed, K ;
Wang, HM ;
Hu, JB ;
Wang, YZ ;
Yao, XB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :20049-20057